• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[骨肉瘤患者辅助化疗的生存情况及预后]

[Survival and prognosis in adjuvant chemotherapy for osteogenic sarcoma patients].

作者信息

Trapeznikov N N, Erëmina L A, Kutateladze T O, Siniukov P A, Amiraslanov A T

出版信息

Vopr Onkol. 1984;30(7):33-40.

PMID:6589872
Abstract

The effect of adjuvant chemotherapy on survival and prognosis in osteogenic sarcoma versus basic clinico-roentgenomorphological characteristics of tumor was studied in 108 cases. Prognosis was found to depend on patient's age, site and size of tumor, but mainly on the roentgeno-morphological pattern of the latter. Osteolytic form appeared to have a better course in cases of adjuvant chemotherapy. This was matched by osteoplastic form requiring surgical treatment only. The results suggest a strictly differentiated approach to selection of treatment modality, particularly in cases of post-operative chemotherapy.

摘要

对108例骨肉瘤患者,研究了辅助化疗对其生存及预后的影响,并与肿瘤的基本临床-放射形态学特征进行对比。结果发现,预后取决于患者年龄、肿瘤部位及大小,但主要取决于肿瘤的放射形态学类型。在辅助化疗的情况下,溶骨型的病程似乎较好。这与仅需手术治疗的成骨型情况相符。结果提示,在选择治疗方式时应采取严格的差异化方法,尤其是在术后化疗的情况下。

相似文献

1
[Survival and prognosis in adjuvant chemotherapy for osteogenic sarcoma patients].[骨肉瘤患者辅助化疗的生存情况及预后]
Vopr Onkol. 1984;30(7):33-40.
2
Post operative infection and increased survival in osteosarcoma patients: are they associated?骨肉瘤患者术后感染与生存率提高:二者有关联吗?
Ann Surg Oncol. 2007 Oct;14(10):2887-95. doi: 10.1245/s10434-007-9483-8. Epub 2007 Jul 26.
3
[Preoperative and postoperative chemotherapy of osteogenic sarcoma of the limbs in children].[儿童肢体骨肉瘤的术前与术后化疗]
Med Clin (Barc). 1996 Jun 29;107(5):161-4.
4
Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience.骨肉瘤的化疗。斯堪的纳维亚肉瘤研究组的经验。
Acta Orthop Scand Suppl. 1999 Jun;285:74-82.
5
Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.原发性转移性骨肉瘤:接受新辅助骨肉瘤协作研究组方案治疗患者的表现及预后
J Clin Oncol. 2003 May 15;21(10):2011-8. doi: 10.1200/JCO.2003.08.132.
6
Significant recent advances in the treatment of osteogenic sarcoma.骨肉瘤治疗领域近期取得的重大进展。
Isr J Med Sci. 1993 Nov;29(11):748-53.
7
[The role of polychemotherapy in the management of malignant bone tumors].[多药联合化疗在恶性骨肿瘤治疗中的作用]
Chirurg. 2002 Dec;73(12):1170-3. doi: 10.1007/s00104-002-0555-9.
8
[Primary chemotherapy with the Rosen T10 protocol before conservative surgery in limb primitive osteosarcomas: results about 56 cases].肢体原发性骨肉瘤保肢手术前采用罗森T10方案进行初始化疗:56例病例结果
Bull Cancer. 2000 Feb;87(2):183-8.
9
[Results of therapy for osteogenic sarcoma in children: perspectives of improvement].[儿童骨肉瘤的治疗结果:改善前景]
Vopr Onkol. 1997;43(4):420-2.
10
Osteosarcoma in adolescents and young adults: new developments and controversies. The Mayo Clinic studies.青少年和青年骨肉瘤:新进展与争议。梅奥诊所研究。
Cancer Treat Res. 1993;62:333-8.